Prospectus supplement US007924AH66 - Aegon

General
We will describe in the related prospectus supplement or, if applicable, the pricing supplement the
terms of each series of warrants to purchase securities, which may include debt securities, common
shares or the equity or debt of issuers unaffiliated with us, the warrant agreement relating to the
warrants offered and the warrant certificates representing the warrants offered. These terms will
include some or all of the following:
• the title of the warrants offered;
• the securities, which may include debt securities, common shares or the equity or debt of issuers
unaffiliated with us, for which you may exercise the warrants;
• the aggregate number of the warrants;
• the number of securities that you may purchase upon exercise of each warrant, and the price or
prices at which we will issue the warrants;
• the currency or currencies investors may use to pay for the warrants;
• the procedures and conditions relating to the exercise of the warrants;
• the designation and terms of any related securities issued with the warrants, and the number of
warrants issued with each security;
• the date, if any, from which you may separately transfer the warrants and the related securities;
• the date on which your right to exercise the warrants commences, and the date on which your
right expires;
• whether we will issue the warrants or the underlying securities in registered form or bearer form;
• information with respect to book-entry procedures, if any;
• the maximum or minimum number of warrants which you may exercise at any time;
• if applicable, a discussion of material United States federal income tax considerations;
• a description of your rights to institute and maintain any suit, action or proceeding to enforce
your rights to exercise and receive the securities purchasable upon exercise of your warrants;
• a description of any antidilution provisions applicable to the warrants that would require
adjustment of the number of securities purchasable or the exercise price of your warrants, or
both;
• the identity of the warrant agent; and
• any other terms of the warrants, including terms, procedures and limitations relating to your
exchange and exercise of the warrants.
We will also describe in the related prospectus supplement or, if applicable, the pricing supplement
any provisions for a change in the exercise price or the expiration date of the warrants and the kind,
frequency and timing of any notice to be given. You may exchange warrant certificates for new warrant
certificates of different denominations and may exercise warrants at the corporate trust office of the
warrant agent or any other office that we indicate in the related prospectus supplement or, if
applicable, the pricing supplement. Prior to the exercise of your warrants, you will not have any of the
rights of holders of the underlying securities purchasable upon exercise of the warrants and will not be
entitled to dividend, interest or any other payments, if any, or voting rights of the underlying securities
purchasable upon such exercise.
24